LifeStance Health (LFST) Change in Receivables (2020 - 2026)

LifeStance Health has disclosed Change in Receivables across 7 years of filings, most recently posting $27.0 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 214.58% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at -$17.7 million (up 50.22% YoY), while the FY2025 annual figure was -$36.1 million, down 664.2% from the prior year.
• Change in Receivables grew to $27.0 million in Q1 2026, from -$25.4 million in the prior quarter.
• Over the last five years, Change in Receivables for LFST reached as high as $50.5 million in Q1 2024 and fell as low as -$26.4 million in Q4 2024.
• The 5-year median for Change in Receivables is $3.4 million (2023), against an average of $2.5 million.
• The widest YoY moves for Change in Receivables: up 481.55% in 2022, down 469.59% in 2022.
• A 5-year view of Change in Receivables shows it stood at -$12.9 million in 2022, then plunged by 87.82% to -$24.3 million in 2023, then retreated by 8.44% to -$26.4 million in 2024, then rose by 3.78% to -$25.4 million in 2025, then surged by 206.27% to $27.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $27.0 million, -$25.4 million, and -$8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.